We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
OneSpan
OSPN
$618M
| $4.71M | ﹤0.01% |
168,572
-122,445
| -42% | -$2.41M |
|
1927
Puma Biotechnology
PBYI
$454M
| $4.71M | ﹤0.01% |
451,140
-28,388
| -6% | -$294K |
|
1928
TC Energy
TRP
$65.9B
| $4.68M | ﹤0.01% |
109,274
-132,567
| -55% | -$5.95M |
|
1929
Ennis
EBF
$564M
| $4.68M | ﹤0.01% |
257,853
+34,081
| +15% | +$601K |
|
1930
MarineMax
HZO
$788M
| $4.67M | ﹤0.01% |
208,559
-1,970
| -0.9% | -$32.4K |
|
|
CHCT
1931
Community Healthcare Trust
CHCT
$454M
| $4.64M | ﹤0.01% |
113,491
+31,748
| +39% | +$1.19M |
|
1932
Alamo Group
ALG
$2.05B
| $4.64M | ﹤0.01% |
45,167
-1,183
| -3% | -$113K |
|
1933
Archrock
AROC
$5.8B
| $4.63M | ﹤0.01% |
714,114
+5,638
| +0.8% | +$29.5K |
|
|
RDUS
1934
DELISTED
Radius Health, Inc.
RDUS
| $4.63M | ﹤0.01% |
339,385
-210,683
| -38% | -$2.9M |
|
1935
Kadant
KAI
$3.99B
| $4.62M | ﹤0.01% |
46,367
+2,783
| +6% | +$248K |
|
|
KAMN
1936
DELISTED
Kaman Corp
KAMN
| $4.62M | ﹤0.01% |
111,037
-55,805
| -33% | -$2.16M |
|
|
NVO
1937
Novo Nordisk
NVO
$209B
| $4.62M | ﹤0.01% |
141,064
-538
| -0.4% | -$17.2K |
|
1938
Immunovant
IMVT
$8.25B
| $4.61M | ﹤0.01% |
+189,151
| New | +$4.05M |
|
1939
HUTCHMED
HCM
$2.17B
| $4.61M | ﹤0.01% |
166,990
-10,870
| -6% | -$236K |
|
1940
Kontoor Brands
KTB
$4.26B
| $4.6M | ﹤0.01% |
258,434
-72,947
| -22% | -$1.3M |
|
1941
US Physical Therapy
USPH
$1.22B
| $4.6M | ﹤0.01% |
56,816
+254
| +0.4% | +$18.5K |
|
|
AFMD
1942
DELISTED
Affimed
AFMD
| $4.59M | ﹤0.01% |
+99,579
| New | +$2.77M |
|
1943
Restaurant Brands International
QSR
$25.8B
| $4.59M | ﹤0.01% |
84,097
-91
| -0.1% | -$4.59K |
|
1944
Astec Industries
ASTE
$1.02B
| $4.58M | ﹤0.01% |
98,930
+10,467
| +12% | +$429K |
|
1945
Independent Bank Corp
IBCP
$844M
| $4.58M | ﹤0.01% |
308,396
-68,696
| -18% | -$949K |
|
1946
Horizon Bancorp
HBNC
$1.04B
| $4.57M | ﹤0.01% |
427,628
+93,049
| +28% | +$949K |
|
1947
News Corp Class B
NWS
$17.5B
| $4.57M | ﹤0.01% |
382,530
-13,455
| -3% | -$146K |
|
1948
Coca-Cola Consolidated
COKE
$12.8B
| $4.56M | ﹤0.01% |
199,090
-9,880
| -5% | -$231K |
|
1949
Vroom Inc
VRM
$48.2M
| $4.56M | ﹤0.01% |
+1,094
| New | +$4.24M |
|
1950
Greif
GEF
$5.04B
| $4.56M | ﹤0.01% |
132,500
+18,637
| +16% | +$612K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.